Business, energy, technology, markets and global industry news from Business News Today

Lyme disease

PharmaDeviceNews Lyme disease
Representative image: Moderna’s early hantavirus vaccine work highlights how mRNA vaccine platforms could support rare-virus preparedness as outbreak-driven concerns renew focus on infectious disease innovation.
Pharma & Biotech

Pfizer’s Lyme vaccine showed 73% efficacy, but missed a statistical hurdle. What comes next?

Pfizer will present 57 infectious disease abstracts at IDWeek 2026, including Phase 3 Lyme vaccine findings, new pediatric pneumococcal data and real-world RSV effectiveness studies. The programme highlights pipeline progress while leaving important regulatory and clinical questions unresolved.

Read More
Representative image of an at-home Lyme disease testing kit with tick prevention essentials, illustrating the growing consumer focus on Better Life Science, Tick Bite Hero, and spring tick season awareness.
Medical Devices & Diagnostics

Why Better Life Science’s Lyme testing push matters more for access than for diagnosis alone

Better Life Science is pushing at-home Lyme testing this spring. Read what Tick Bite Hero changes, where it fits, and what risks remain.

Read More